Video

Cheryl Larson Provides Assistance to Employers Managing High-Cost Specialty Drugs

Employers who manage the high cost of care associated with specialty pharmacy face a number of challenges that are being addressed by the National Employer Initiative on Specialty Pharmacy, said Cheryl Larson, BA, vice president of the Midwest Business Group on Health.

Employers who manage the high cost of care associated with specialty pharmacy face a number of challenges that are being addressed by the National Employer Initiative on Specialty Pharmacy, Cheryl Larson, BA, vice president of the Midwest Business Group on Health, said at the AMCP’s 27th Annual Meeting & Expo in San Diego, April 7-10.

Among the ways the Initiative is looking to help is an online toolkit focusing on 3 key areas: providing the average employer with a better understanding of biologic and specialty drugs; benefit plan design and vendor contracting; and tools and resources to support the consumer.

“We know that we’ve done a pretty good job providing additional information and awareness to the average employer, but nobody is talking to the average consumer about this new world of high-cost drugs,” she explained.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Rakendu Rajendran, MBBS
Vivek Bhalla, MD, Stanford University School of Medicine
Rayan Salih, MD, Northeast Georgia Health System
Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, Mount Sinai Fuster Heart Hospital
Varsha Tanguturi, MD, MPH, Mass General Hospital
 Khush Kharidia, MD, UT Southwestern
Alexandra M. Trevino, MD, Northwestern Medicine
Andrew Kuykendall, MD, Moffitt Cancer Center
David J. Maron, MD, FASPC, Stanford University School of Medicine
Karen Vo talks about antibullying campaigns and pediatric patients with derm conditions
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo